BGM0504
A Study of BGM0504 in Participants With Obesity
BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 96
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| BGM0504 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Tirzepatide | Obesity or overweight | n/r | n/r | n/r | n/r |